Corbus Pharmaceuticals to Present Virtually at the H.C. Wainwright 24th Annual Global Investment Conference

Rhea-AI Summary

Corbus Pharmaceuticals Holdings (NASDAQ: CRBP) announced that CEO Yuval Cohen will present virtually at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022. The presentation will be available on-demand starting September 12, 2022, at 7:00 AM ET for registered attendees, accessible for 30 days on the conference platform. Corbus focuses on immunology and is committed to innovative treatments targeting serious illnesses, with a pipeline that includes anti-integrin monoclonal antibodies and small molecules for the endocannabinoid system.

NORWOOD, Mass., Sept. 12, 2022 /PRNewswire/ -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) ("Corbus" or the "Company"), today announced that Yuval Cohen, Ph.D., Chief Executive Officer of Corbus, will present virtually at the H.C. Wainwright 24th Annual Global Investment Conference.   The hybrid conference will take place September 12-14, 2022. 

A livestream of the virtual presentation is available on-demand beginning today, Monday, September 12, 2022 at 7:00 AM ET for those who are registered to attend the conference and will be accessible for 30 days on the H.C. Wainwright conference platform. For more information, please visit the conference website.

About Corbus

Corbus is an immunology company committed to helping people defeat serious illness by bringing innovative scientific approaches to well understood biological pathways.  Corbus' current pipeline includes anti-integrin monoclonal antibodies that block activation of TGFβ and small molecules that activate or inhibit the endocannabinoid system. Corbus is headquartered in Norwood, Massachusetts. For more information on Corbus, visit corbuspharma.com. Connect with us on Twitter, LinkedIn and Facebook.

INVESTOR CONTACT:
Sean Moran
smoran@corbuspharma.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/corbus-pharmaceuticals-to-present-virtually-at-the-hc-wainwright-24th-annual-global-investment-conference-301621611.html

SOURCE Corbus Pharmaceuticals

FAQ

When is Corbus Pharmaceuticals presenting at the H.C. Wainwright conference?

Corbus Pharmaceuticals will present virtually at the H.C. Wainwright 24th Annual Global Investment Conference from September 12-14, 2022.

Who is the CEO of Corbus Pharmaceuticals?

The CEO of Corbus Pharmaceuticals is Yuval Cohen, Ph.D.

How can I access the Corbus Pharmaceuticals presentation?

The presentation can be accessed on-demand starting September 12, 2022, at 7:00 AM ET for registered attendees.

What is the focus of Corbus Pharmaceuticals?

Corbus Pharmaceuticals focuses on immunology and developing innovative treatments for serious illnesses.

What is the stock symbol for Corbus Pharmaceuticals?

The stock symbol for Corbus Pharmaceuticals is CRBP.